Cargando…
Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir
The fixed-dose combination of Efavirenz/Emtricitabine/Tenofovir is a first-line agent for the treatment of HIV; however few cases have reported hepatotoxicity associated with the drug. We report a case of Efavirenz/Emtricitabine/Tenofovir-associated hepatotoxicity presenting mainly with hepatocellul...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487274/ https://www.ncbi.nlm.nih.gov/pubmed/26161275 http://dx.doi.org/10.1155/2015/280353 |
_version_ | 1782378976949305344 |
---|---|
author | Patil, Rashmee Ona, Mel A. Papafragkakis, Haris Carey, Jeanne Moshenyat, Yitzchak Alhaddad, Adib Anand, Sury |
author_facet | Patil, Rashmee Ona, Mel A. Papafragkakis, Haris Carey, Jeanne Moshenyat, Yitzchak Alhaddad, Adib Anand, Sury |
author_sort | Patil, Rashmee |
collection | PubMed |
description | The fixed-dose combination of Efavirenz/Emtricitabine/Tenofovir is a first-line agent for the treatment of HIV; however few cases have reported hepatotoxicity associated with the drug. We report a case of Efavirenz/Emtricitabine/Tenofovir-associated hepatotoxicity presenting mainly with hepatocellular injury characterized by extremely elevated aminotransferase levels, which resolved without acute liver failure or need for liver transplant referral. |
format | Online Article Text |
id | pubmed-4487274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-44872742015-07-09 Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir Patil, Rashmee Ona, Mel A. Papafragkakis, Haris Carey, Jeanne Moshenyat, Yitzchak Alhaddad, Adib Anand, Sury Case Reports Hepatol Case Report The fixed-dose combination of Efavirenz/Emtricitabine/Tenofovir is a first-line agent for the treatment of HIV; however few cases have reported hepatotoxicity associated with the drug. We report a case of Efavirenz/Emtricitabine/Tenofovir-associated hepatotoxicity presenting mainly with hepatocellular injury characterized by extremely elevated aminotransferase levels, which resolved without acute liver failure or need for liver transplant referral. Hindawi Publishing Corporation 2015 2015-06-16 /pmc/articles/PMC4487274/ /pubmed/26161275 http://dx.doi.org/10.1155/2015/280353 Text en Copyright © 2015 Rashmee Patil et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Patil, Rashmee Ona, Mel A. Papafragkakis, Haris Carey, Jeanne Moshenyat, Yitzchak Alhaddad, Adib Anand, Sury Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir |
title | Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir |
title_full | Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir |
title_fullStr | Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir |
title_full_unstemmed | Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir |
title_short | Acute Liver Toxicity due to Efavirenz/Emtricitabine/Tenofovir |
title_sort | acute liver toxicity due to efavirenz/emtricitabine/tenofovir |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487274/ https://www.ncbi.nlm.nih.gov/pubmed/26161275 http://dx.doi.org/10.1155/2015/280353 |
work_keys_str_mv | AT patilrashmee acutelivertoxicityduetoefavirenzemtricitabinetenofovir AT onamela acutelivertoxicityduetoefavirenzemtricitabinetenofovir AT papafragkakisharis acutelivertoxicityduetoefavirenzemtricitabinetenofovir AT careyjeanne acutelivertoxicityduetoefavirenzemtricitabinetenofovir AT moshenyatyitzchak acutelivertoxicityduetoefavirenzemtricitabinetenofovir AT alhaddadadib acutelivertoxicityduetoefavirenzemtricitabinetenofovir AT anandsury acutelivertoxicityduetoefavirenzemtricitabinetenofovir |